Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: history of present illness: ms. was in her usual state of health until three days prior to admission when she began to have fevers, nonproductive cough, worsening shortness of breath, and dyspnea on exertion. on the day of admission, these symptoms became worse, and they were not relieved by her rescue albuterol inhaler. she then found that her peak flow was down to 90 from a baseline of 200 to 250. therefore, she went to the emergency department. on presentation to the emergency department, her vital signs were a temperature of 99.2, blood pressure of 153/73, heart rate in the 130s, respiratory rate of 22, and an oxygen saturation of 97% on room air. her peak flow was measured to be in the 90s in the emergency department, with her baseline at home noted to be 200. a chest x-ray showed hyperinflated lungs with no infiltrate. she was requiring albuterol nebulizers every hour and was not showing improvement while in the emergency department. therefore, she was admitted to the intensive care unit. while in the medical intensive care unit an arterial blood gas was obtained, from which she was found to have a ph of 7.28, a pco2 of 29, and a po2 of 76, with a lactate level of 6.6. urinalysis showed a ph of 5, trace ketones, and a glucose of greater than 1000. at 5:30 p.m. arterial blood gas showed a lactate level peaking at 10.2, with a ph of 7.29, and a bicarbonate level of 11. with this presentation, bowel ischemia was considered. an abdominal ct was performed which was negative for ischemia or abnormalities. she then had an episode of chest pain which occurred on the way to the ct scan which she regarded as anxiety. a 12-lead electrocardiogram at that time was negative for ischemia. she was subsequently ruled out by enzymes with creatine kinases being negative times four, and troponin i being negative times three q.6h. she was started on intravenous solu-medrol at 60 mg t.i.d., and on admission to the floor was switched over to prednisone 60 mg p.o. q.d. past medical history: (her past medical history includes) 1. asthma times five years. 2. hypertension. 3. hyperlipidemia. medications on admission: medications at (preadmission) included pulmicort, serevent, flovent, albuterol, combivent, zocor, glucophage, glyburide, avapro, premarin, accolate, and cyclobenzaprine. allergies: she has no known drug allergies. social history: the patient lives with her husband. as a manager of a house for the care of mentally disabled people. no recent travel. no change of residence. no pets. no tobacco. husband smokes infrequently. the patient reports having had house renovated a couple of weeks ago. family history: family history was positive for diabetes. mother recently died of chronic renal failure related to her diabetes. physical examination on presentation: vital signs revealed temperature of 98.3, heart rate of 89, blood pressure of 134/88, respiratory rate of 18, oxygen saturation of 95% on room air and 100% on 4 liters. in general, a mildly obese african-american woman in mild respiratory discomfort. head, eyes, ears, nose, and throat revealed extraocular movements were intact. pupils were equal, round, and reactive to light (3 mm to 2 mm). the oropharynx was clear without erythema, moist mucous membranes. neck was supple. carotids were 2+ bilaterally without bruits. no thyromegaly. no upper airway wheezing. chest revealed bilateral symmetric excursions, expiratory and inspiratory wheezes throughout. no costovertebral angle tenderness. heart had a regular rate and rhythm. no third heart sound or fourth heart sound. no murmurs. the abdomen was soft, protuberant, nontender and nondistended, normal bowel sounds. stool was guaiac-negative in the emergency department. extremities revealed no ankle edema, no calf tenderness or swelling, 2+ dorsalis pedis pulses bilaterally. pertinent laboratory data on presentation: laboratories revealed complete blood count with white blood cell count of 12.8, hematocrit of 12.1, platelets of 381. chem-7 revealed sodium of 140, potassium of 4.1, chloride of 106, bicarbonate of 24, blood urea nitrogen of 16, creatinine of 0.7, glucose of 182. creatine kinases were 124, 146, and 150. ck/mb was 22, troponin of less than 0.3. arterial blood gas revealed ph of 7.34, pco2 of 39, po2 of 73, with a lactate level of 1.7. assessment: a 58-year-old woman with severe asthma, type 2 diabetes mellitus (on metformin) presenting with an asthma exacerbation. the patient seems to have had about one week of worsening upper respiratory tract infection symptoms; probably a viral upper respiratory infection preceding this admission, which most likely led to the exacerbation. a transient episode of lactic acidosis of unknown etiology, now resolving; possibly due to side effect of metformin. hospital course: 1. asthma: on admission, peak flows were at less than 50% of predicted value at 90. the patient was started on intravenous solu-medrol and then switched to oral prednisone 60 mg p.o. q.d. she is now completing third day at 60 mg. subjectively better; peak flows now in the 180 range to 200 range. the patient was continued on home regimen of meter-dosed inhalers and q.4h. albuterol nebulizers, now spaced out to p.r.n. which she received one to two times per day. for her asthma, she will be sent to complete her prednisone taper and was written for three days of prednisone p.o. q.d. at 40 mg, then 20 mg p.o. q.d. for three days, then 10 mg p.o. q.d. for three days. she will continue on her flovent meter-dosed inhaler 220 mg 3 puffs b.i.d., atrovent , albuterol, serevent, and accolate (which were unchanged). 2. diabetes: the patient reported having high blood sugars in the 400 range for about two weeks before admission. blood sugars during her hospital stay continued to be elevated. control was difficult, especially with the patient on corticosteroids. sliding-scale nph was added while the patient was in the hospital to help control blood sugar levels. the patient will be leaving on an adjusted control regimen due to metformin being discontinued secondary to an episode of lactic acidosis. glyburide was changed to glipizide by recommendation of the diabetic service who were following her throughout her stay. the patient was to go home on glipizide 10 mg p.o. q.d., actos 30 mg p.o. q.d., and nph sliding-scale for additional coverage while finishing her prednisone taper. 3. constipation: the patient reported that she had not had a bowel movement since being admitted to the hospital. a kub on the fifth day of admission showed no free air, no signs of perforation, and no signs of obstruction with retained contrast throughout the bowel. she was put on a regimen for her constipation including colace, dulcolax, and fleet enemas. on the night prior to discharge, she had a large bowel movement overnight with subsequent relief of her symptoms of bloating. the patient is much more comfortable now after having a large bowel movement. she was instructed to stay actively ambulating, to stay well hydrated, and to add fiber to her diet. she was to continue on over-the-counter anti-constipations medications p.r.n. at home. current episode of constipation was probably due to a combination of inactivity, poor p.o. fluid intake, and low fiber diet. 4. disposition: the patient was to continue on her preadmission preventative medications including aspirin 81 mg p.o. q.d. and protonix 40 mg p.o. q.d. she was to follow up with her primary care doctor, dr. ; who was made aware of the details of her hospital stay and her medication changes. dr. was in agreement with the treatment plan, and she will follow ms. over the next couple of week; every two to three days by phone to follow blood sugar levels and nph dosing while ms. is being tapered from her prednisone for an asthma exacerbation. discharge diagnoses: acute asthma exacerbation. discharge status: discharged to home. code status: full code. discharge followup: the patient was to follow up with her primary care physician, . , within the next two to three weeks in person and every two to three days for nph adjustments. the patient was interested in following with diabetes care specialist. the decision on this issue will be left to her primary care physician. medications on discharge: 1. prednisone taper 40 mg p.o. q.d. times three days; then 20 mg p.o. q.d. times three days; then 10 mg p.o. q.d. times three days. 2. flovent meter-dosed inhaler 220 mcg 3 puffs b.i.d. 3. atrovent meter-dosed inhaler 2 puffs q.i.d. 4. albuterol meter-dosed inhaler 2 puffs q.4-6h. p.r.n. 5. serevent meter-dosed inhaler 2 puffs b.i.d. 6. accolate 20 mg p.o. b.i.d. 7. glipizide 10 mg p.o. q.d. 8. actos 30 mg p.o. q.d. 9. nph sliding-scale starting at 25 units q.a.m. and 10 units q.p.m. 10. aspirin 81 mg p.o. q.d. 11. protonix 40 mg p.o. q.d. 12. zocor 40 mg p.o. q.d. 13. avapro 150 mg p.o. q.d. , m.d. dictated by: medquist36 procedure: arterial catheterization diagnoses: acidosis pure hypercholesterolemia unspecified essential hypertension constipation, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled asthma, unspecified type, with (acute) exacerbation 

Answer: The patient is high likely exposed to